Advertisement
  • Decoding Disparities in Colorectal Cancer

    People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.

    by Marci A. Landsmann

  • Nudging Our Way to Better Cancer Care

    Researchers use insights from behavioral economics to encourage taking recommended actions in health care.

    by Kevin McLaughlin

  • Post-surgery Option for Liver Cancer

    New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.

    by Thomas Celona

  • Chronic Stress and Cancer

    Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.

    by Thomas Celona

  • Forward Look

    Progress in Personalized Cancer Vaccines

    Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.

    by Thomas Celona

  • The HPV Vaccine Prevents Cancer. Why Do Many Cancer Survivors Not Get It?

    A recent study investigated why some young cancer survivors did not want the HPV vaccine and how they can be better served.

    by Pamela Rafalow Grossman

  • Forward Look

    The Pitfalls of Polypharmacy

    Many older adults take multiple medications, which can potentially interfere with their cancer treatment.

    by Ashley P. Taylor

  • Facts and Stats

    Counting the Cost

    Cancer deaths linked to cigarette smoking account for millions of years in lost lives and billions of dollars in economic burden.

    by Thomas Celona

  • Add It Up

    Immunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.

    by Kendall K. Morgan

  • Colorectal Cancer in Young People

    While colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age 50. Younger people are more likely to be diagnosed at a later stage and have unique challenges that come with facing cancer in their prime.

    by Erin O’Donnell